Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Discov ; 3: 17026, 2017.
Article in English | MEDLINE | ID: mdl-28761722

ABSTRACT

TBX5 is a vital transcription factor involved in cardiac development in a dosage-dependent manner. But little is known about the potential association of TBX5 3' untranslated region (UTR) variations with congenital cardiac malformations. This study aimed to investigate the relationship between TBX5 3'UTR variants and risk for congenital heart disease (CHD) susceptibility in two Han Chinese populations, and to reveal its molecular mechanism. The relationship between TBX5 3'UTR variants and CHD susceptibility was examined in 1 177 CHD patients and 990 healthy controls in two independent case-control studies. Variant rs6489956 C>T was found to be associated with increased CHD susceptibility in both cohorts. The combined CHD risk for the CT and TT genotype carriers was 1.83 times higher than that of CC genotype, while the risk for CT or TT genotype was 1.94 times and 2.31 times higher than that of CC carriers, respectively. Quantitative real-time PCR and western blot analysis showed that T allele carriers exhibited reduced TBX5 mRNA and protein levels in CHDs tissues. Compared with C allele, T allele showed increased binding affinity to miR-9 and miR-30a in both luciferase assays and surface plasmon resonance analysis. Functional analysis confirmed that miR-9 and miR-30a downregulated TBX5 expression at the transcriptional and translational levels, respectively. The assays in zebrafish model were in support of the interaction of miR-9/30a and TBX5 3'UTR (C and T allele). We concluded that TBX5 3'UTR variant rs6489956 increased susceptibility of CHD in the Han Chinese population because it changes the binding affinity of two target miRNAs that specifically mediate TBX5 expression.

2.
Sci Rep ; 4: 5302, 2014 Jun 16.
Article in English | MEDLINE | ID: mdl-24931632

ABSTRACT

Bulk metallic glasses exhibit high strength and large elastic strain limit but have no tensile ductility. However, bulk metallic glass composites reinforced by in-situ dendrites possess significantly improved toughness but at the expense of high strength and large elastic strain limit. Here, we report a bulk metallic glass composite with strong strain-hardening capability and large elastic strain limit. It was found that, by plastic predeformation, the bulk metallic glass composite can exhibit both a large elastic strain limit and high strength under tension. These unique elastic mechanical properties are attributed to the reversible B2↔B19' phase transformation and the plastic-predeformation-induced complicated stress state in the metallic glass matrix and the second phase. These findings are significant for the design and application of bulk metallic glass composites with excellent mechanical properties.

3.
Eur Heart J ; 35(11): 733-42, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23798577

ABSTRACT

AIMS: Elevated homocysteine levels are known to be a risk factor for congenital heart disease (CHD), but the mechanism underlying this effect is unknown. During early embryonic development, homocysteine removal is dictated exclusively by the MTR activity. To examine the role of MTR in CHD risk, we identified genetic variants in MTR and investigated the mechanisms that affect its expression levels and that increase the risk of CHD in Chinese populations. METHODS AND RESULTS: The association between regulatory variants of the MTR gene and CHD was examined in three independent case-control studies in a total of 2340 patients with CHD and 2270 controls. The functional consequences of these variants were demonstrated using dual-luciferase assays, real-time polymerase chain reaction (PCR), electrophoretic mobility shift assays, surface plasma resonance, chromatin immunoprecipitation, and bisulfite sequencing, as well as by a group of predicted microRNAs using a gene reporter system. Two regulatory variants of MTR, -186T>G and +905G>A, were associated with an increased risk of CHD in both the separate and combined case-control studies (-186GG P = 1.32 × 10(-9); +905AA P = 6.35 × 10(-14)). Compared with the major allele, the -186G allele exhibited significantly lower promoter activity, decreased hnRNA and mRNA levels, reduced transcription factor binding affinity, and a more highly methylated promoter. The +905A allele exhibited a statistically stronger binding affinity to functional microRNAs that down regulate MTR expression at the translational level. Both of the minor alleles were correlated with elevated plasma homocysteine concentrations, indicating a genetic component for hyperhomocysteinaemia. CONCLUSIONS: Regulatory variants of the MTR gene increase CHD risk by reducing MTR expression and inducing the homocysteine accumulation and elevation.


Subject(s)
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase/genetics , Heart Defects, Congenital/genetics , Asian People/genetics , Case-Control Studies , DNA Methylation/genetics , Ferredoxin-NADP Reductase/genetics , Gene Expression/genetics , Genetic Predisposition to Disease/genetics , Genotype , Homocysteine/metabolism , Humans , Hyperhomocysteinemia/genetics , MicroRNAs/genetics , Risk Factors , Transcription, Genetic/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...